Over the last 10 years, breakthroughs in understanding the genetic instructions passed from parent to offspring have put ...

Among 47 patients with any of several forms of idiopathic inflammatory myositis (IIM) who took efgartigimod (Vyvgart Hytrulo) ...

Study reveals the advantages and pitfalls of adding a TKI to a monoclonal antibody after chemoradiation for non-small cell ...

Measles is on the rise in Canada and poses serious risks to pregnant people and their newborns, yet discussion about how to ...

Panelists discuss how the management of immunoglobulin A (IgA) nephropathy is undergoing a transformative shift from symptom control to targeted disease modification, with emerging therapies offering ...

Ontario's chief medical officer of health says six infants have been born with congenital measles since an outbreak began ...

The following is a summary of “Burden of corticosteroid therapy in patients with immunoglobulin A nephropathy (IgAN): a ...

A novel immunoglobulin A nephropathy (IgAN) drug cut proteinuria in half, according to interim findings from the ongoing ...

A subanalysis of the NeflgArd study shows benefits in eGFR and urine protein-creatinine ratio at baseline and across ...

Researchers observed inequities in receipt of first-line preferred therapies among a cohort of patients with chronic ...

Otsuka's investigational antibody sibeprenlimab approximately halved levels of this key biomarker in patients with ...